top of page
News and Features
Search
Mar 18, 2021
How should we collect, share and analyse clinical breast/ovarian cancer genomics data?
The first in our Genomics Ethics blog series from work package 6. Unpacking the top line ethical issues within cancer genetics.
Jan 14, 2021
Virtual Pan Programme Meeting 2021: Registration Open
We would like to invite you to the CanGene-CanVar Pan Programme Meeting 2021 taking place over two afternoons on Wednesday 10th and...
Jun 18, 2020
Investigator Focus: Prof. Clare Turnbull and germ cell testicular cancer
For Men’s Health Week we learn more about Prof. Clare Turnbull's research in the area of testicular cancer.
Feb 20, 2020
Pan Program Meeting 2020: Setting the scene
Clare Turnbull (CGCV), Ellen Graham (NHS England) and Lauren Blackburn (PHG Foundation) kick start the pan program meeting.
Feb 20, 2020
Pan Program Meeting 2020: Making Record Linkage Work
Session two focused around the work to link multiple national datasets and securely release the datasets for analysis by CGCV researchers.
Feb 20, 2020
Pan Program Meeting 2020: Variants and Risk - Resources for Clinical Laboratories
In session 3, speakers discuss the challenges around cancer genetic variant interpretation and introduce the resources overcoming these.
Feb 20, 2020
Pan Program Meeting 2020: Improving clinician understanding and management of risk
In session 4, we had an exciting range of talks covering the educational and resource needs for different areas of the clinical community.
Feb 20, 2020
Pan Program Meeting: The patient perspective and ethical considerations
Our final session covered the benefit that CGCV outputs are having for patients and how our PPI group are having valuable input to research.
Feb 11, 2020
#WomenInScience
Tuesday 11 February 2020 is International Day of Women and Girls in Science. Here we introduce the women leading CGCV research activities.
Jan 13, 2020
Utilising cancer susceptibility genetics for early detection and prevention of cancer
With genomic testing becoming increasingly embedded into routine NHS care, better evidence is required to underpin cancer genetic testing.
bottom of page